The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Ibrutinib maintenance following induction for untreated mantle cell lymphoma (MCL): Initial safety report.
 
Reem Karmali
Honoraria - Prime Oncology
Consulting or Advisory Role - Juno Therapeutics; Kite/Gilead
Speakers' Bureau - AstraZeneca; Kite/Gilead
Research Funding - Bristol-Myers Squibb (Inst); Gilead Sciences (Inst); MedImmune (Inst); Takeda (Inst)
Travel, Accommodations, Expenses - Prime Oncology
 
Jeremy S. Abramson
Consulting or Advisory Role - Abbvie; Amgen; Bayer; Celgene; EMD Serono; Genentech; Gilead Sciences; Janssen; Juno Therapeutics; Karyopharm Therapeutics; Kite, a Gilead company; Merck; Novartis; Seagen; Verastem
Research Funding - AI Therapeutics (Inst); Celgene (Inst); genentech (Inst); Juno Therapeutics (Inst); Seagen (Inst)
 
Deborah Marie Stephens
Honoraria - Genentech
Research Funding - Acerta Pharma; Gilead Sciences; Karyopharm Therapeutics
 
Jeffrey A. Barnes
No Relationships to Disclose
 
Jason B. Kaplan
Consulting or Advisory Role - Seagen
Research Funding - Janssen (Inst); Seagen (Inst)
Travel, Accommodations, Expenses - Curis
 
Jane N. Winter
Consulting or Advisory Role - Abbvie (I); Adicet Bio; Amgen (I); Ariad (I); Bayer; Boston Biomedical (I); Celgene (I); CVS Caremark (I); Dava Oncology (I); Gilead Sciences; Janssen; Janssen; Merck; Novartis (I)
Research Funding - Astellas Pharma (Inst); Celgene (I); Curis; Daiichi Sankyo (I); ERYTECH Pharma (Inst); GlaxoSmithKline (Inst); Janssen Oncology (Inst); Merck
Patents, Royalties, Other Intellectual Property - Royalties from UptoDate, Inc. (I)
Travel, Accommodations, Expenses - Adicet Bio; Bayer; Gilead Sciences; Janssen; Merck
 
Shuo Ma
Consulting or Advisory Role - Abbvie; AstraZeneca; bioverativ; Genentech/Roche; Gilead Sciences; Janssen Oncology; Novartis; Omniprex; Pharmacyclics
Speakers' Bureau - AstraZeneca; Genentech/Roche; Janssen Oncology; Pharmacyclics
Research Funding - Abbvie (Inst); Acerta Pharma (Inst); Gilead Sciences (Inst); Incyte (Inst); Novartis (Inst); Pharmacyclics (Inst)
 
Adam Matthew Petrich
Employment - Abbvie
Stock and Other Ownership Interests - Abbvie
 
Ephraim P. Hochberg
Stock and Other Ownership Interests - Flatiron Health; Intervention Insights; Leuko
Consulting or Advisory Role - Intervention Insights
 
Tak Takvorian
No Relationships to Disclose
 
Valerie Nelson
Consulting or Advisory Role - AstraZeneca
Travel, Accommodations, Expenses - AstraZeneca
 
Leo I. Gordon
Consulting or Advisory Role - Bayer; Gilead Sciences; Juno Therapeutics
Patents, Royalties, Other Intellectual Property - Zylem
 
Barbara Pro
Honoraria - Celgene; kiowa; Seagen; Takeda
Research Funding - Celgene (Inst); takeda (Inst)
Travel, Accommodations, Expenses - Seagen; takeda